RIO DE JANEIRO, BRAZIL - July began with good news as the experimental vaccine against the novel coronavirus produced by pharmaceutical giant Pfizer in partnership with biotechnology company BioNTech has yielded positive results in limited human trials. The vaccine has encouraged an immune response in healthy patients but has also . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here